| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Ispinesib Mesylate | GDSC1000 | pan-cancer | AAC | 0.084 | 0.009 |
| mRNA | IOX2 | GDSC1000 | pan-cancer | AAC | -0.089 | 0.009 |
| mRNA | SB-743921 | CTRPv2 | pan-cancer | AAC | 0.087 | 0.01 |
| mRNA | 3-Cl-AHPC | CTRPv2 | pan-cancer | AAC | 0.089 | 0.01 |
| mRNA | CHIR-99021 | GDSC1000 | pan-cancer | AAC | -0.083 | 0.01 |
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | 0.095 | 0.01 |
| mRNA | CP724714 | GDSC1000 | pan-cancer | AAC | 0.087 | 0.01 |
| mRNA | Methotrexate | GDSC1000 | pan-cancer | AAC | 0.076 | 0.01 |
| mRNA | SNX-2112:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.085 | 0.01 |
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | 0.093 | 0.01 |